Nasdaq Warns Exact Sciences of Noncompliance with $50M Market Cap Minimum | GenomeWeb
NEW YORK (GenomeWeb News) – Exact Sciences has received notice from the Nasdaq Stock Market that it is not in compliance with the Nasdaq Global Market’s listing’s requirement of a minimum $40 million market capitalization, the company said today.
 
Exact Sciences’ market cap is currently $36.4 million.
 
The company has 30 calendar days, or until Aug. 11, to regain compliance by maintaining a minimum $50 million market value for at least 10 consecutive business days.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.